載入...
Targeting lung cancer through inhibition of checkpoint kinases
Inhibitors of checkpoint kinases ATR, Chk1, and Wee1 are currently being tested in preclinical and clinical trials. Here, we review the basic principles behind the use of such inhibitors as anticancer agents, and particularly discuss their potential for treatment of lung cancer. As lung cancer is on...
Na minha lista:
| 發表在: | Front Genet |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4343027/ https://ncbi.nlm.nih.gov/pubmed/25774168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2015.00070 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|